Effect of Shengmai injection (生脉注射液) on vascular endothelial and heart functions in patients with coronary heart disease complicated with diabetes mellitus
Back to article page
|Updated:2021-08-27
|
Effect of Shengmai injection (生脉注射液) on vascular endothelial and heart functions in patients with coronary heart disease complicated with diabetes mellitus
Chinese Journal of Integrative MedicineVol. 14, Issue 4, Pages: 281-285(2008)
Affiliations:
1. Department of Internal Cardiology, Xinhua Hospital Affiliated to Shanghai Jiaotong University,Shanghai,China
2. Department of Laboratory, Ruijin Hospital, Shanghai Jiaotong University School of Medicine,Shanghai,China
Zhang, Yc., Lu, Bj., Zhao, Mh. et al. Effect of Shengmai injection (生脉注射液) on vascular endothelial and heart functions in patients with coronary heart disease complicated with diabetes mellitus., Chin. J. Integr. Med. 14, 281 (2008). https://doi.org/10.1007/s11655-008-0281-3
Ya-chen Zhang, Bao-jing Lu, Mei-hua Zhao, et al. Effect of Shengmai injection (生脉注射液) on vascular endothelial and heart functions in patients with coronary heart disease complicated with diabetes mellitus. [J]. Chinese Journal of Integrative Medicine 14(4):281-285(2008)
Zhang, Yc., Lu, Bj., Zhao, Mh. et al. Effect of Shengmai injection (生脉注射液) on vascular endothelial and heart functions in patients with coronary heart disease complicated with diabetes mellitus., Chin. J. Integr. Med. 14, 281 (2008). https://doi.org/10.1007/s11655-008-0281-3DOI:
Ya-chen Zhang, Bao-jing Lu, Mei-hua Zhao, et al. Effect of Shengmai injection (生脉注射液) on vascular endothelial and heart functions in patients with coronary heart disease complicated with diabetes mellitus. [J]. Chinese Journal of Integrative Medicine 14(4):281-285(2008) DOI: 10.1007/s11655-008-0281-3.
Effect of Shengmai injection (生脉注射液) on vascular endothelial and heart functions in patients with coronary heart disease complicated with diabetes mellitus
摘要
To study the effect of Shengmai injection (生脉注射液
SMI) on vascular endothelial and heart functions in coronary heart disease patients complicated with diabetes mellitus (CHD-DM). One hundred and twenty patients with CHD-DM
their diagnosis confirmed by coronary arteriography
were equally randomized into a control group treated with conventional treatment and a treated group treated with conventional treatment plus SMI. The changes in blood levels of nitric oxide (NO)
endothelin-1 (ET-1) and angiotensin II (Ang II)
as well as endothelium-dependent vascular dilating function and heart function in the patients were observed before treatment and after the 3-week treatment. After being treated with SMI for 3 weeks
in the treated group
blood level of NO was raised significantly from 69.8 ± 33.1 μ mol/L to 120.1 ± 50.8 μ mol/L
and ET-1 was lowered from 70.1 ± 32.1 ng/L to 46.2 ± 21.3 ng/L
respectively (P<0.01); that of Ang II was lowered from 81.3 ± 24.3 ng/L to 50.2 ± 27.3 ng/L (P<0.01); brachial arterial post-congestion blood flow increasing rate was raised from 389.4 ± 26.3% to 459.3 ± 27.8% (P<0.01); and the improvement in heart function as seen through the ejection fraction (EF) was increased from 44 ± 5% to 68 ± 6% (P<0.01)
all the changes being more significant than those in the control group (all P<0.01). SMI can improve not only the endothelial function in CHD-DM patients
but also heart contraction significantly.
Abstract
To study the effect of Shengmai injection (生脉注射液
SMI) on vascular endothelial and heart functions in coronary heart disease patients complicated with diabetes mellitus (CHD-DM). One hundred and twenty patients with CHD-DM
their diagnosis confirmed by coronary arteriography
were equally randomized into a control group treated with conventional treatment and a treated group treated with conventional treatment plus SMI. The changes in blood levels of nitric oxide (NO)
endothelin-1 (ET-1) and angiotensin II (Ang II)
as well as endothelium-dependent vascular dilating function and heart function in the patients were observed before treatment and after the 3-week treatment. After being treated with SMI for 3 weeks
in the treated group
blood level of NO was raised significantly from 69.8 ± 33.1 μ mol/L to 120.1 ± 50.8 μ mol/L
and ET-1 was lowered from 70.1 ± 32.1 ng/L to 46.2 ± 21.3 ng/L
respectively (P<0.01); that of Ang II was lowered from 81.3 ± 24.3 ng/L to 50.2 ± 27.3 ng/L (P<0.01); brachial arterial post-congestion blood flow increasing rate was raised from 389.4 ± 26.3% to 459.3 ± 27.8% (P<0.01); and the improvement in heart function as seen through the ejection fraction (EF) was increased from 44 ± 5% to 68 ± 6% (P<0.01)
all the changes being more significant than those in the control group (all P<0.01). SMI can improve not only the endothelial function in CHD-DM patients
but also heart contraction significantly.
关键词
Shengmai Injectioncoronary heart diseasediabetes mellitusvascular endothelial functionheart function
Keywords
Shengmai Injectioncoronary heart diseasediabetes mellitusvascular endothelial functionheart function
references
Drexler H. Endothelial dysfunction: clinical implications. Prog Cardiovasc Dis 1997;39:287–324.
Kjaer A, Meyer C, Nielsen FS, et al. Dipyridamole, cold pressor test, and demonstration of endothelial dysfunction: a PET study of myocardial perfusion in diabetes. J Nucl Med 2003;44:19–23.
Rask-Madsen C, Ihlemann N, Krarup T, et al. Torp-Pedersen C: Insulin therapy improves insulin-stimulated endothelial function in patients with type 2 diabetes and ischemic heart disease. Diabetes 2001;50:2611–2618.
Miki Horigome, Naoya Hattori, Mitsuaki Horigome, et al. Quantitative measurements of coronary endothelial function in type 2 diabetic patients with coronary risk factors. Circ J 2007; 71(Suppl):296p.
Zhang YC, Chen RM, Zhao MH, et al. Effect of Shengmai Injection (生脉注射液) on hemodynamics in patients with dilated cardiomyopathy. Chin J Integr Tradit West Med (Chin) 2002;22(4):277–279.
Chen YM, Yang JX, Sha W, et al. Effect of Sheng-mai-san injection vs Astragalus membranaceus injection in treating coronary heart disease with left ventricular dysfunction. Chin J New Drugs Clin Remedies (Chin) 1998;17(3):27–29.
Zhang YC, Zhao MH, Lu BJ, et al. Effects of Shengmai injection in the treatment of acute myocardial infarction with left ventricular dysfunction. Acad J Shanghai Second Med Univ 2004;24(8):692.
Celermajer DS, Sorensen KE, Gooch VM, et al. Noninvasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111–1115.
Rubanyi GM. The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol 1993;22(Suppl 4):S1–S14.
Vogel RA. Coronary risk factors, endothelial function, and atherosclerosis: a review. Clin Cardiol 1997;20:426–432.
Celermajer DS, Sorensen KE, Gooch VM, et al. Noninvasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111–1115.
Arcaro G, Cretti A, Balzano S, et al. Insulin causes endothelial dysfunction in humans: sites and mechanisms. Circulation 2002;105:576–582.
Lu BJ, Rong YZ, Zhao MH, et al. Effect of Shengmaisan (生脉散) on lipid peroxidation damage in acute myocardial infarction patients. Chin J Integr Tradit West Med 1996;2(4):249–251.
Zhang YC, Cheng RM, Lu BJ, et al. Effect of Shengmai Injection (生脉注射液) on cardiac function and inflammatory reaction in patients with acute coronary syndrome. Chin J Integr Med 2008;14(2):107–110.